QuantaLife's technology has become part of Bio-Rad’s ddPCR platform, indicating a potential opportunity to align with Bio-Rad’s broader sales motions and leverage Bio-Rad’s large customer base for cross-sell of ddPCR related kits, reagents, and services
QuantaLife's technology has become part of Bio-Rad’s ddPCR platform, indicating a potential opportunity to align with Bio-Rad’s broader sales motions and leverage Bio-Rad’s large customer base for cross-sell of ddPCR related kits, reagents, and services.